Through these mechanistic understandings of PERK-NRF2’s role in protecting cancer cells from oxidative stress, inhibition of PERK-NRF2 pathway is revealed as potentially an effective strategy to combine with ROS-inducing or ferroptosis-inducing agents for cancer therapies. Here, EIF2AK3 is linked to cancer.